3-amino-1,5-dihydro-5-methyl-I-beta-D-ribofuranosyl-1,4,5,6,8- pentaazaacenaphthylene,
6-amino-4-methyl-8-(beta-D-ribofuranosyl)-(4H,8H)pyrrolo(4,3,2-de)pyrimido(4,5-c)pyridazine,
6-ARPPP,
NSC 154020,
NSC 154120,
NSC-154020,
triciribine,
Triciribine,
35943-35-2,
Tricyclic nucleoside,
Pentaazacentopthylene,
Tricirbine,
NSC 154020,
Triciribine [INN],
API-2,
Triciribinum [INN-Latin],
Triciribina [INN-Spanish],
UNII-2421HMY9N6,
BRN 1171593,
C13H16N6O4,
NSC-154020,
1,5-Dihydro-5-methyl-1-beta-D-ribofuranosyl-1,4,5,6,8-pentaazaacenaphthylen-3-amine,
CHEBI:65310,
TCN,
2421HMY9N6,
Inhibitor V,
1,4,5,6,8-Pentaazaacenaphthylen-3-amine, 1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl-,
1,4,5,6,8-Pentaazaacenaphthylene, 3-amino-1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl-,
3-Amino-1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl-1,4,5,6,8-pentaazaacenaphthylene,
DSSTox_CID_25743,
DSSTox_RID_81088,
DSSTox_GSID_45743,
Triciribina,
Triciribinum,
5-methyl-1-(beta-D-ribofuranosyl)-1,5-dihydro-1,4,5,6,8-pentaazaacenaphthylen-3-amine,
(2R,3R,4S,5R)-2-(3-amino-5-methyl-1,4,5,6,8-pentaazaacenaphthylen-1(5H)-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol,
CAS-35943-35-2,
VD-0002,
6-ARPPP,
Akt/PKB Signaling Inhibitor-2,
CHEMBL331237,
NCGC00092314-01,
NCGC00092314-04,
API-2;Triciribine,
Triciribine/API-2,
NSC 154120,
BiomolKI2_000078,
SCHEMBL61268,
MLS006011145,
AC1L236J,
DTXSID6045743,
CTK8F0953,
AOB5912,
EX-A415,
BCPP000034,
HMS3677I03,
ZINC3808299,
Tox21_111192,
2082AH,
2765AH,
ABP000410,
BDBM50369528,
MFCD16879015,
s1117,
API-2;NSC 154020;TCN,
AKOS024456958,
Tox21_111192_1,
CCG-100678,
DB12405,
SB14594,
1,4,5,6,8-Pentaazaacennaphthylen-3-amine, 1,5-dihydro-5-methyl-1-.beta.-D-ribofuranosyl-,
3-amino-1,5-dihydro-5-methyl-I-beta-D-ribofuranosyl-1,4,5,6,8- pentaazaacenaphthylene,
6-amino-4-methyl-8-(beta-D-ribofuranosyl)-(4H,8H)pyrrolo(4,3,2-de)pyrimido(4,5-c)pyridazine,
NCGC00092314-02,
NCGC00092314-06,
4CA-1279,
AN-16846,
BC638573,
SMR002530325,
SRI-10809-03,
DB-048898,
LS-101390,
TX-018033,
FT-0639291,
W-5227,
943T352,
BRD-K80431395-001-01-6,
BRD-K80431395-001-09-9,
1,4,5,6,8-Pentaazaacenaphthylen-3-amine,1,5-dihydro-5-methyl-1-b-D-ribofuranosyl-,
1,4,5,6,8-Pentaazaacennaphthylen-3-amine, 1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl-,
1,5-Dihydro-5-methyl-1-?-D-ribofuranosyl-1,4,5,6,8-pentaazaacenaphthylen-3-amine,
1,5-Dihydro-5-methyl-1-beta-D-ribofuranosyl-1,4,5,6,8pentaazaacenaphthylen-3-amine,
(2R,3R,4S,5R)-2-{5-amino-7-methyl-2,6,7,9,11-pentaazatricyclo[6.3.1.0^{4,12}]dodeca-1(11),3,5,8(12),9-pentaen-2-yl}-5-(hydroxymethyl)oxolane-3,4-diol,
1,4,5,6,8-Pentaazaacennaphthylen-3-amine, 1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl- (9CI),
TRICIRIBINE PHOSPHATE,
cc-615,
NSC154020,
CID65399,
NCGC00014417,
C13-H16-N6-O4,
A8541,
A13210,
C023764,
Triciribine, 98%, a DNA synthesis inhibitor - 25MG 25mg,
(2R,3R,4S,5R)-2-[amino(methyl)[?]yl]-5-(hydroxymethyl)tetrahydrofuran-3,4-diol,
6-Amino-4-methyl-8-(-D-ribofuranosyl)-4H,8H-pyrrolo[4,3,2-de]pyrimido[4,5-c]pyridazine,